Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Cash & Equivalents (2016 - 2026)

Cannabis Suisse has reported Cash & Equivalents over the past 10 years, most recently at $75.0 for Q1 2026.

  • Quarterly Cash & Equivalents rose 50.0% to $75.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $75.0 through Feb 2026, up 50.0% year-over-year, with the annual reading at $2850.0 for FY2025, 90.02% down from the prior year.
  • Cash & Equivalents was $75.0 for Q1 2026 at Cannabis Suisse, down from $2625.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $38339.0 in Q4 2022 and troughed at $44.0 in Q1 2024.
  • The 5-year median for Cash & Equivalents is $2737.5 (2025), against an average of $8203.4.
  • The largest YoY upside for Cash & Equivalents was 14252.76% in 2024 against a maximum downside of 99.13% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $38339.0 in 2022, then crashed by 85.8% to $5444.0 in 2023, then dropped by 24.69% to $4100.0 in 2024, then crashed by 35.98% to $2625.0 in 2025, then plummeted by 97.14% to $75.0 in 2026.
  • Per Business Quant, the three most recent readings for CSUI's Cash & Equivalents are $75.0 (Q1 2026), $2625.0 (Q4 2025), and $305.0 (Q3 2025).